Stocks / NASDAQ / Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.

Our Opinion

Cipher Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

Company’s Product profile report – ACTIKERALL

┬áThe following report cites the company’s usage of animals for testing drugs.
“The animals showed sedation and respiratory symptoms with cyanosis and death caused by dyspnea.” (Page 20)

Company Description

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States. [Source: GoogleFinance]

Company Website: http://www.cipherpharma.com